Protective Life Insurance Fit Review for Epilepsy and Seizure Disorders

Research Snapshot

Why Protective Life Qualified for This Study

Questions This Section Answers

• Is Protective Life a good choice for life insurance for epilepsy and seizure disorders?
• Why did only three of seven AI platforms name Protective Life for epilepsy life insurance?

Protective Life qualified because three of the seven platforms in this study named it during ranking discovery, and it cleared the study's two-mention minimum. It was not a unanimous pick. Perplexity ranked it first, anthropic ranked it sixth, and kimi ranked it eighth, producing an average listed rank of 5.0 across the platforms that named it (anthropic, kimi, perplexity).

The entity also qualified on substance rather than name recognition alone. Every platform that evaluated Protective identified a real, relevant product for this use case: Protective Classic Choice Term, a fully underwritten term policy, plus selected universal life products ^[1]. Fully underwritten coverage matters for epilepsy because it allows an underwriter to review seizure type, frequency, time since the most recent seizure, medications, treatment compliance, and neurological records rather than relying on a short simplified-issue questionnaire ^[8].

Protective's published product materials describe three underwriting paths for Classic Choice Term — instant, accelerated, and traditional — with possible no-exam issuance for qualifying applicants ^[12]. The product guide lists 10-, 15-, 20-, 25-, 30-, 35-, and 40-year term options, a $100,000 minimum face amount, and underwriting classes based on current health and medical history ^[1]. That combination is why platforms treated Protective as worth evaluating even though none could confirm how it treats epilepsy specifically.

The Product, Model, Plan, or Service Most Relevant to Life Insurance for Epilepsy and Seizure Disorders

Questions This Section Answers

• Which Protective Life product should a buyer with epilepsy apply for, and does it require a medical exam?
• Is Protective Classic Choice Term available in New York for an applicant with a seizure disorder?

Protective Classic Choice Term is the product most relevant to this use case, and it is a fully underwritten term policy rather than a simplified-issue or guaranteed-issue product. Platforms converged on this product more than any other Protective offering ^[13].

The published product guide describes a minimum face amount of $100,000, multiple term durations, and underwriting classes based on current health and medical history ^[13]. Protective's underwriting flyer describes instant, accelerated, and traditional underwriting paths, with possible no-exam issuance for qualifying applicants ^[19]. Traditional underwriting may involve exams, medical records, and additional information, while accelerated underwriting may avoid an Attending Physician Statement or fluids ^[20]. Protective's consumer materials describe a medical-history phone interview, paramedical exam, blood and urine collection, underwriting review, and an approximate four-to-six-week process ^[21].

Two product-level restrictions matter directly for this use case. First, Protective's PLUS accelerated underwriting eligibility materials list epilepsy, seizures, paralysis, or mental/nervous disorder as conditions that can make an applicant ineligible for the accelerated path ^[22]. Second, Protective application materials ask whether the proposed insured has been diagnosed or treated for nervous disorders such as seizures within the past 10 years, which confirms seizure history is directly underwritten ^[24].

Classic Choice Term has no cash value, premiums increase after the initial guaranteed premium period, and the product is not available in New York according to Protective's published disclosure ^[26]. Perplexity reported that Classic Choice (TL-21) is issued in all states except New York, where a different issuer and form apply ^[16].

Protective also offers universal life products, which some platforms flagged as a permanent-coverage alternative ^[27]. However, the public materials reviewed do not establish that a particular Protective universal life policy is preferable for applicants with epilepsy, and permanent coverage involves more complex funding, cash-value, and lapse considerations than term coverage ^[26].

What the AI Platforms Agreed About

Questions This Section Answers

• What do AI platforms agree on about Protective Life for epilepsy life insurance?
• Does Protective Life require full medical underwriting for an applicant with a seizure disorder?

The platforms agreed on four points, and the agreement on the first two was unanimous across all seven responses.

First, every platform identified Protective as a mainstream, fully underwritten carrier whose relevant product for this use case is term life, with universal life as a secondary option ^[30]. No platform described Protective as a guaranteed-issue or simplified-issue carrier for this condition.

Second, every platform that addressed underwriting agreed that epilepsy pushes an applicant toward full medical underwriting rather than a fast, no-exam path. Protective's own PLUS eligibility materials list epilepsy and seizures as conditions that can block accelerated underwriting ^[37], and Protective's application asks about nervous disorders including seizures within the prior 10 years ^[39]. Independent underwriting guidance for seizure disorders says underwriters commonly consider seizure type, number of seizures, diagnosis date, time since last seizure, and medication changes ^[41].

Third, platforms agreed that Protective publishes no epilepsy-specific underwriting guidelines, rate classes, or pricing. This was stated as a limitation by openai, anthropic, deepseek, perplexity, and kimi ^[30]. No platform produced a Protective-specific epilepsy rate table.

Fourth, platforms agreed that a buyer with epilepsy should compare Protective against other carriers rather than treat it as a confirmed best option. Openai, anthropic, deepseek, perplexity, and kimi all recommended comparison or prescreening through a broker experienced with impaired-risk or epilepsy cases ^[30].

Where the AI Platforms Disagreed or Were Uncertain

The platforms disagreed on overall fit rating and on how favorably Protective treats controlled epilepsy. Fit ratings split as follows: google and kimi rated Protective "good," openai, deepseek, grok, and perplexity rated it "mixed," and anthropic rated it "uncertain."

The sharpest disagreement concerns rating outcomes. Grok reported that Protective evaluates seizure type, frequency, time since last seizure, medications, and compliance, with 2+ years seizure-free on medication typically producing Table 2–4 ratings, 1–2 years producing Table 4–6, and recent seizures producing Table 6–8 or decline ^[49]. Google reported that well-controlled seizure disorders can qualify for Standard rates while active cases or grand mal histories can trigger table ratings ^[50]. Kimi reported that applicants seizure-free for 2+ years on stable medications may qualify for standard to mild table ratings ^[51]. Openai, anthropic, deepseek, and perplexity did not confirm any of these thresholds for Protective specifically and stated that Protective's treatment of seizure type, frequency, recency, medication adherence, and driving restrictions is unclear ^[53].

The platforms also disagreed on whether Protective uses a dual-manual underwriting strategy. Google reported that Protective uses Swiss Re and Hannover Re manuals and applies the more favorable rating of the two, which it said can improve table scores for medical applicants ^[57]. No other platform reported this, and it was not corroborated by any other supplied source.

A third disagreement concerns accelerated underwriting. Kimi reported that Protective's Express Term accelerated underwriting may be available for well-controlled cases without an exam ^[51]. Perplexity and google reported the opposite for epilepsy specifically, citing Protective materials that list epilepsy and seizures as disqualifiers for the accelerated path ^[58]. The company-owned eligibility checklist supports the exclusion reading.

A fourth uncertainty concerns rider eligibility. Google reported that epilepsy with seizures within the last year, or new-onset seizures of unknown cause, is a medical disqualifier for Protective's Chronic Illness Accelerated Death Benefit and ExtendCare rider ^[60]. No other platform addressed rider eligibility for this condition.

Finally, no platform produced independent evidence of Protective's approval rate, average premium, or customer outcomes for epilepsy or seizure disorders ^[53].

Use-Case-Specific Features and Capabilities

Protective's most relevant capability for this use case is that traditional underwriting can allow a detailed review of a stable, well-documented seizure disorder rather than relying only on a short simplified-issue questionnaire ^[64]. Protective's process includes a medical-history interview and may include a paramedical exam, blood and urine samples, and medical-record review ^[66]. These requirements are relevant to documenting seizure history, diagnosis, medications, specialist care, and treatment compliance, but Protective does not publish a seizure-specific checklist ^[64].

Coverage structure is a second capability. Classic Choice Term lists 10-, 15-, 20-, 25-, 30-, 35-, and 40-year options subject to issue-age and underwriting restrictions, with a published minimum face amount of $100,000 and no stated maximum face amount in the product guide ^[64]. Perplexity reported term options of 10, 15, 20, 25, 30, 35, or 40 years depending on state and product details ^[68]. Anthropic reported term and universal life capacity up to $50 million for ages 18 to 85, citing an independent review ^[69].

Conversion rights are a third capability. Anthropic reported that Protective term policies include a conversion privilege allowing a switch to permanent coverage without another medical exam, with conversion windows varying by original term length — 8 years on a 10-year term, 13 years on a 15-year term, and 18 years on 20-, 25-, or 30-year terms ^[70]. Kimi reported similar conversion privileges to Custom Choice UL ^[73]. This matters for a buyer whose seizure status may change, because it can lock in permanent coverage access without re-underwriting.

Financial strength was reported by anthropic, citing independent reviews: an A+ (Superior) AM Best rating, other ratings from S&P, Moody's, and Fitch, a history dating to 1907 or 1909 depending on the source, and most claims processed within 3–4 weeks ^[74]. These are platform-reported figures from independent review sites, not verified in this study.

Two capability limits apply. Epilepsy and seizures can make an applicant ineligible for the accelerated underwriting path ^[77]. And epilepsy with seizures in the last year, or new-onset seizures of unknown cause, is a reported disqualifier for the Chronic Illness Accelerated Death Benefit and ExtendCare rider ^[79].

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

• How much does Protective Life cost per month for a buyer with epilepsy, and are there epilepsy-specific fees?
• What contract terms should a buyer with a seizure disorder verify before signing a Protective Life policy?

No epilepsy-specific premium or reliable public rate example for a buyer with a seizure disorder was found by any platform. Pricing confidence was rated low by openai, deepseek, and perplexity, and moderate by anthropic, grok, kimi, and google. Protective states that quoted premiums are estimates until underwriting is complete ^[80].

The only concrete pricing figures supplied are for standard health classes, not epilepsy. Anthropic reported sample rates of $42 per month for a woman and $54 per month for a man at age 40 for a $500,000, 20-year term in a preferred class, and reported that Protective's term rates are below average for every age group under 70 ^[81]. Anthropic also reported universal life discounts reaching up to 20% below market ^[83]. These figures come from an independent review site and do not apply to a rated epilepsy case.

For rated cases, platforms reported different loading estimates. Grok reported that table ratings increase premiums 25–200%+ depending on rating, with Table 2 adding roughly 50% ^[84]. Google reported that a table rating such as Table B or higher can add 50% to 100%+ to the standard base rate depending on seizure severity and frequency ^[85]. Kimi reported that table ratings typically add about 25% per table above standard ^[86]. These three estimates conflict and none is Protective-specific.

On fees, google reported a policy fee typically around $60–$90 annually built into the quoted premium, plus optional rider premiums, and stated that no-cost exam and lab services are covered by Protective when using approved paramedical vendors ^[85]. Perplexity reported that no separate policy or application fees were verified in the public sources it reviewed, and that rider pricing was not verified ^[87]. Deepseek reported possible policy fees, rider charges, and, for universal life, cost-of-insurance and administrative charges depending on the specific policy ^[88].

On contract terms, Classic Choice Term has no cash value and premiums increase after the initial guaranteed premium period ^[89]. Protective policies include up to a two-year contestable and suicide period ^[90]. Grok reported a 31-day grace period and conversion to permanent coverage without new underwriting within the term, varying by length ^[91]. Kimi reported a 30-day free-look period and a typical 31-day grace period ^[86]. Deepseek reported a state-law free-look period allowing return of the policy within a set number of days, with exact length varying by state and product ^[88]. Product availability and policy provisions vary by state and policy form ^[89].

Best Suited For

Questions This Section Answers

• Who is Protective Life best suited for among buyers with epilepsy or a seizure disorder?
• Is Protective Life worth it for an applicant with well-controlled epilepsy seeking term coverage?

Protective is best suited to applicants with well-documented, medically managed, and sufficiently stable seizure disorders who want term coverage and are willing to complete full medical underwriting. This was the common thread across platforms that rated it favorably and those that rated it mixed ^[92].

Specific buyer profiles that platforms identified as reasonable fits:

• Applicants seeking term coverage with a face amount of at least $100,000, the published minimum ^[92].
• Applicants willing to undergo traditional underwriting, including a paramedical exam and possible medical-record review ^[92].
• Applicants whose seizure disorder is well documented, medically managed, and stable enough for an underwriter to evaluate ^[92].
• Applicants with a long seizure-free history on stable medication, which some platforms associated with standard or mild table ratings ^[95].
• Buyers who want conversion rights to permanent coverage without re-underwriting later ^[104].
• Applicants who want an independent broker to compare Protective against other carriers' impairment-risk underwriting ^[94].

Probably Not Best Suited For

Protective is probably not the best fit for applicants who need guaranteed acceptance or coverage without meaningful health underwriting. No platform identified a Protective guaranteed-issue or simplified-issue product as a recommended option for this use case ^[108].

Other profiles platforms flagged as poor fits:

• Applicants with recent, frequent, unexplained, or poorly documented seizures who need a carrier known to publish condition-specific underwriting guidance ^[108].
• Applicants with uncontrolled or recent-onset seizure disorders, described by anthropic as less than 3–6 months seizure-free and by kimi as under 1–2 years ^[112].
• Applicants who need rapid approval without a medical exam, because epilepsy and seizures can block Protective's accelerated underwriting path ^[114].
• Applicants seeking the lowest possible premium without comparing several carriers' offers and final rate classes ^[108].
• Applicants in New York seeking Classic Choice Term, because Protective's published disclosure states the product is not available there ^[116].
• Buyers seeking a carrier explicitly marketed as a high-risk or impaired-risk specialist for epilepsy ^[112].

When Another Option May Be Better

Another carrier or an independent broker may be better when the applicant has recent or frequent seizures and needs comparison among carriers with different medical underwriting manuals ^[118]. Industry sources cited by anthropic emphasize that underwriting posture toward stable, well-controlled epilepsy varies sharply across carriers, with some evaluating controlled epilepsy with nuance and others applying conservative assumptions that produce a decline or heavily rated offer ^[119].

A different product class may be better when the applicant needs guaranteed-issue or simplified-issue coverage and accepts lower coverage amounts or higher premiums ^[118]. Kimi reported that simplified-issue premiums may cost less than heavily rated traditional coverage when table ratings reach Table 6 or higher, and named Mutual of Omaha, Gerber, and AIG as examples in the guaranteed-issue or final-expense space ^[123]. Those carrier names are platform-reported and were not independently verified in this study.

A different carrier may be better when the applicant needs New York coverage or a product form unavailable in the applicant's state ^[124]. And a different insurer may be better when the buyer needs permanent coverage and another insurer provides clearer policy illustrations, funding requirements, and guarantees for the intended objective ^[118].

Anthropic specifically named Transamerica as a carrier that sources cite as consistently offering competitive epilepsy rates and flexible tonic-clonic seizure underwriting ^[119]. That is a platform-reported comparison, not a verified finding, and it should be checked with a broker.

Questions to Verify Before Buying

Questions This Section Answers

• What should a buyer with epilepsy confirm with Protective Life before signing a contract?
• Will Protective Life provide an informal underwriting assessment before a formal application?

The questions below consolidate the verification items platforms raised. They are the items a buyer should resolve before submitting a formal application, because a formal application can create a record with the Medical Information Bureau and a decline can affect later applications ^[126].

• Will the application be evaluated under instant, accelerated, or traditional underwriting given the applicant's seizure history ^[127]?
• What medical records are required, including neurologist notes, EEG or imaging results, medication history, emergency-room records, and seizure diary information ^[127]?
• How will the underwriter treat seizure type, frequency, date of the most recent seizure, known cause, medication adherence, breakthrough seizures, and driving restrictions ^[127]?
• Will the applicant receive a standard, preferred, substandard, postponed, or declined offer, and can Protective provide an informal preliminary assessment before a formal application ^[127]?
• What seizure-free duration is required for the desired rate class, and does medication stability matter ^[131]?
• Are there state-specific exclusions, riders, policy amendments, or restrictions relevant to the applicant ^[127]?
• What are the guaranteed premium periods, annual increases, renewal terms, conversion rights, and deadlines for the exact policy form ^[134]?
• Is Classic Choice Term available in the applicant's state, and which Protective entity will issue the policy ^[134]?
• What are the total premiums and projected costs for the full intended coverage period compared with at least three competing carriers ^[127]?
• If the applicant is declined or rated heavily, will Protective permit reconsideration after additional seizure-free time or updated neurological records ^[127]?
• Are any exam, medical-record, policy-fee, or premium-payment costs charged separately from the quoted premium ^[127]?
• Does the applicant's epilepsy history restrict eligibility for specific riders such as the Chronic Illness Accelerated Death Benefit or ExtendCare rider ^[138]?

Final AI Consensus Verdict

Protective Life is a mixed fit for life insurance buyers with epilepsy or seizure disorders. Three of seven platforms named it during ranking discovery, and fit ratings split across the panel: two "good," four "mixed," and one "uncertain." No platform identified Protective as a specialized or clearly superior epilepsy-friendly insurer.

The case for considering Protective rests on Protective Classic Choice Term: a fully underwritten product with published term lengths of 10 to 40 years, a $100,000 minimum face amount, and a traditional underwriting path that can accommodate detailed documentation of a stable seizure disorder ^[139]. Conversion rights to permanent coverage without re-underwriting were reported by multiple platforms as a meaningful benefit for a buyer whose condition may change ^[141].

The case against treating Protective as a confirmed best option rests on missing evidence. Protective publishes no epilepsy-specific underwriting guidelines, rate classes, or pricing ^[139]. Epilepsy and seizures can block the accelerated underwriting path ^[148]. Table-rating estimates for controlled epilepsy conflict across platforms, ranging from roughly 25% per table to 50–100%+ depending on severity ^[150]. And no independent evidence establishes Protective's approval rate, average premium, or customer outcomes for this condition.

The practical conclusion supported by the supplied evidence: obtain an informal underwriting assessment, compare Protective's final offer against multiple carriers, and use a broker experienced with epilepsy or impaired-risk cases before submitting a formal application. Buyers who want to see how Protective compares with other carriers named in this study can review the full Life Insurance for Epilepsy and Seizure Disorders consensus index, and readers exploring other condition categories can browse the broader life insurance directory.

How This Review Was Produced

This review was produced from a single research run dated 2026-09-22 covering seven AI platforms: openai (gpt-5.6-luna), anthropic (claude-haiku-4-5-20251001), deepseek (deepseek-v4-flash), grok (x-ai/grok-4.3), kimi (moonshotai/kimi-k2.6), perplexity (perplexity/sonar), and google (gemini-3.5-flash). Six of the seven had search enabled; deepseek reported search disabled. Each platform answered the same prompt about which life insurance carriers are generally worth considering for applicants with epilepsy or a seizure disorder, and each supplied its own citations, fit rating, pricing notes, and verification questions.

Protective Life was included because it was named by three of the seven platforms during ranking discovery, clearing the study's two-mention minimum. The entity's ranking statistics, fit ratings, product identifications, pricing notes, and limitations were compiled from the platform responses. All platform outputs carry a verification status of platform-reported, not independently verified. No personal testing, customer experience, or independent verification was performed for this review.

Methodology Limitations

Several limitations apply to this review and should be weighed before acting on it.

Platform-reported research dates differ from the authoritative run date. Deepseek reported a research date of 2026-02-14, while the run research date is 2026-09-22. Platform-reported dates are provenance metadata and do not independently prove freshness.

Platform mentions count only platforms that named the entity during ranking discovery. All seven platforms evaluated fit, but only three named Protective during the ranking stage, so the 42.9% share reflects ranking-stage naming, not the breadth of fit evaluation.

Conflicting product names, pricing, and capabilities were not resolved by guessing. Where platforms disagreed — on table-rating loadings, on accelerated underwriting availability for controlled epilepsy, and on whether Protective uses a dual-manual underwriting strategy — this review describes the conflict and identifies what buyers should verify.

The supplied URLs were collected from platform responses and were not independently validated by the writer stage. Citations are platform-reported evidence, not independently verified facts. Claims from platforms without search enabled require explicit verification before being described as current facts.

No public epilepsy-specific underwriting guide, acceptance criteria, or rate table for Protective was identified by any platform. No verified public quote can be given without applicant-specific age, state, coverage amount, term, seizure history, medications, and medical records. No public evidence establishes that Protective is more favorable to epilepsy applicants than competing insurers.